Gusacitinib Uses, Dosage, Side Effects and more
Gusacitinib is under investigation in clinical trial NCT02550678 (A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma).
| Attribute | Details |
|---|---|
| Trade Name | Gusacitinib |
| Generic | Gusacitinib |
| Gusacitinib Other Names | Gusacitinib |
| Type | |
| Formula | C24H28N8O2 |
| Weight | Average: 460.542 Monoisotopic: 460.233522174 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
